Immunovant Inc.

NASDAQ: IMVT
Share price (12/20/24): $25.86
Market cap (12/20/24): $3.796 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q2

ended 06/30/24 Q1

ended 03/31/24 FY 2024

ended 12/31/23 Q3

ended 09/30/23 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Automatic shelf registration

Prospectus supplement for primary offering

Free writing prospectus

Free writing prospectus

Ownership Filter

Van Tuyl Christopher

Van Tuyl Christopher

Hughes Douglas J.

Hughes Douglas J.

News Filter

Provides Development Updates and Reports Financial Results for the Quarter Ended September 30, 2024

Provides Update on Graves’ Disease Development Program

Shareholder Vote Results

Reports Financial Results and Provides Corporate Updates for the Quarter Ended June 30, 2024

Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC